Oscar Health (NYSE:OSCR) Rating Increased to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded shares of Oscar Health (NYSE:OSCR) from a hold rating to a strong-buy rating in a report released on Saturday.

Several other research firms have also recently issued reports on OSCR. Raymond James Financial upgraded shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price on the stock in a research note on Thursday, February 12th. Barclays increased their target price on shares of Oscar Health from $18.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Thursday. Robert W. Baird increased their target price on shares of Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a research note on Thursday. UBS Group increased their target price on shares of Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a research note on Thursday. Finally, Wolfe Research began coverage on shares of Oscar Health in a research note on Tuesday. They issued a “peer perform” rating on the stock. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $18.22.

Oscar Health Stock Up 2.0%

OSCR opened at $21.28 on Friday. The company has a 50 day moving average of $14.43 and a 200 day moving average of $15.29. The company has a market cap of $6.34 billion, a PE ratio of -36.07, a price-to-earnings-growth ratio of 2.84 and a beta of 2.34. Oscar Health has a 12 month low of $10.69 and a 12 month high of $23.80. The company has a current ratio of 0.96, a quick ratio of 0.96 and a debt-to-equity ratio of 0.44.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping the consensus estimate of $1.11 by $0.96. The company had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.73%. Oscar Health’s revenue for the quarter was up 52.6% on a year-over-year basis. During the same period last year, the firm earned $0.92 EPS. On average, sell-side analysts expect that Oscar Health will post 0.34 EPS for the current year.

Insider Activity at Oscar Health

In related news, CEO Mark T. Bertolini purchased 1,000,000 shares of the firm’s stock in a transaction dated Monday, April 6th. The shares were purchased at an average price of $11.92 per share, with a total value of $11,920,000.00. Following the acquisition, the chief executive officer directly owned 10,196,876 shares of the company’s stock, valued at approximately $121,546,761.92. This represents a 10.87% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 24.39% of the stock is owned by insiders.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. increased its holdings in shares of Oscar Health by 2.7% in the 4th quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after buying an additional 540,851 shares during the last quarter. T. Rowe Price Investment Management Inc. raised its holdings in Oscar Health by 11.0% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 9,217,816 shares of the company’s stock valued at $132,461,000 after buying an additional 910,320 shares during the last quarter. Morgan Stanley raised its holdings in Oscar Health by 42.8% during the 4th quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock valued at $97,918,000 after buying an additional 2,043,758 shares during the last quarter. Thrive Capital Management LLC increased its holdings in Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after purchasing an additional 1,588,395 shares during the period. Finally, BIT Capital GmbH increased its holdings in Oscar Health by 545.0% during the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after purchasing an additional 5,227,152 shares during the period. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.